Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro

Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro

Background/Aims: Caffeic acid (CA) is known to possess multiple biological activities including anti-cancer activities. However, the molecular mechanisms underlying these activities in non-small-cell lung cancer (NSCLC) cells are not fully understood. We attempted to clarify whether CA could enhance...

Full description

Bibliographic Details
Main Authors: Jie Min, Hua Shen, Wang Xi, Qing Wang, Liang Yin, Yufeng Zhang, Yue Yu, Qian Yang, Zhi-nong Wang
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2018-07-01
Series:Cellular Physiology and Biochemistry
Subjects:
Lung cancer
Caffeic acid
MAPK signaling
Paclitaxe
Xenograft
Online Access:https://www.karger.com/Article/FullText/492253

Internet

https://www.karger.com/Article/FullText/492253

Similar Items